Equity Research

Our Equity Research team tracks close to 200 stocks across our European Equity Growth universe. This highly focused approach enables the generation of Buy and Sell recommendations for companies where the team has strong convictions. Our analysts have clear-cut opinions and publish over 100 initiation reports and major updates per year.

Pricing growth companies

The result of our research-based approach is an ability to price and select growth companies with long term potential. To do this, we strive to understand a company’s business, reconstructing the underlying business model and applying our proprietary valuation techniques. This methodology gives us the analytical means to price growth shares, the confidence to weather volatile markets and the self-assurance to provide long-term buy recommendations.

Communicating our research

We invest a lot of time sharing our research with our clients. Each month, we initiate formal analyst meetings or roadshows with close to 100 investors across Europe. We publish company reports, industry reports, daily briefs and monthly strategic outlooks, and our analysts proactively advise our clients to make sure that our research has a timely impact.

A research model free from conflicts of interest

Bryan, Garnier & Co’s research team has developed a model which ensures our research is totally independent:

We provide independent and contrarian ideas on mid and large European stocks: our clients value our knowledge and the fact that our team is free from any conflicts of interest arising from global banking relationships with large corporations
We identify attractive mid-cap companies (€500 million to €3 billion) that have limited coverage and represent a hidden investment opportunity for our investors
We ensure equity research coverage of listed small-caps, related to our investment banking activities to make sure that the market is fed with accurate and comprehensive analysis of their newsflow.

Industry sectors

Our focus on growth sectors has brought success and expansion at a time of consolidation and change in investment banking. Our success and expansion during the past decades of consolidation and change in the investment banking industry is due to our dedication and focus on growth.

BG Iris

Corporate Research

Our size and sector specialisms mean that Bryan, Garnier & Co is ideally positioned to provide a focused and insightful research offer. Corporates benefit from in-depth sector expertise and an emphasis on mid-caps, plus a service that goes beyond research to encompass targeted access to investors. Investors get valuable insight into both growth companies and their sectors.

Sector specialism

Coverage from sector experts not only offers a depth of knowledge, but it also means we can deliver a valuable “read across” the sector as a whole and from a global perspective, uncovering more connections and insights. This in-depth focus has led to our opinions being trusted and valued by clients.

Mid-cap focus

While other institutions cover mid-cap companies with generalist teams, Bryan, Garnier & Co brings partner-level insight with a strong focus on mid-caps and their position in their sector. We can help growth companies understand how established players are thinking about specific issues, which gives management teams a complete picture.

Wide range of publications

As well as single-name reports, we also publish white papers, transactional reports and sector reports to offer a greater breadth of insight for corporates and investors.

High-quality relationships

Our service for corporates goes beyond research to encompass access to North American and European investors, high-quality roadshows, conferences and meeting feedback, creating targeted opportunities for valuable relationship-building.